An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome

Kissei

Status and phase: Terminated; Phase 3

Conditions: Dry Eye With Sjögren's Syndrome

Treatments: Drug: KCT-0809 ophthalmic solution

Study type: Interventional

Funder types: Industry

Identifiers

NCT02503176

KCT1302

Details and patient eligibility

About

The purpose of this study is to evaluate of the long-term safety and efficacy of KCT-0809 in dry eye patients with Sjögren's syndrome.

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Dry eye patients with Sjögren's syndrome finished KCT1301 study

Exclusion criteria

• Patients with poor adherence to medication of study drug in KCT1301 study

Trial design

0 participants in 1 patient group

KCT-0809

Experimental group

Treatment:

Drug: KCT-0809 ophthalmic solution